Patrick Duxbury > Gowling WLG > Birmingham, England > Lawyer Profile

Gowling WLG
B4 6WR
Patrick Duxbury photo

Work Department

Intellectual property.


Partner and life sciences team leader, specialising in life sciences transactions of all kinds; also specialises in all aspects of transactional intellectual property law, including IP licensing, R&D collaborations, spin outs and IP strategy; deals include $520m collaboration between Astex Therapeutics and Novartis, $500m collaboration between Astex Therapeutics and Janssen, $1bn deal between Chroma Therapeutics and GSK and acting for GSK on their €400m deal with Morphosys A.G.; numerous transactions for MedImmune (including recent in-licence of a phase II antibody product from Amgen) and acting for various VCs on investments in life sciences companies, acting for Astellas on in-license of a phase III drug from Basilea and Chroma Theraputics on an out licence of the North and South American rights to their drug Tosedostat.


Trained Philip Conn & Co, Manchester; qualified 1993; partner Wragge & Co 1999; Wragge Lawrence Graham & Co, partner, 2014. Regular speaker at conferences and seminars on biotech and pharmaceutical licensing and collaborations; recent member of the Legal Expert network of the Association of British Pharmaceutical Industry. Presenter on the BIO advanced business development course in both the USA and Europe.




Licensing Executives Society; Association of the British Pharmaceutical Industry and the Biotechnology Industry Association.


Queen Elizabeth’s Grammar School; Newcastle University (1989 BSc Hons 2(1)); Chester College of Law (1991 CPE, Distinction; Law Society Finals, First Class Hons).


Football, cricket, skiing, walking, family.